National Study Coordinator
Hudson Institute of Medical Research
Posted 17 hours ago
National Study Coordinator
Australian and New Zealand Children’s Haematology/Oncology Group (ANZCHOG)/
Hudson Institute of Medical Research
Full Time (1.0 FTE)
Excellent Salary Packaging Benefits
Flexible working options, including remote working.
About ANZCHOG
ANZCHOG is the national Cancer Cooperative Trials Group (CCTG) for childhood and adolescent cancer clinical trials and conducts a broad range of national and international trials. ANZCHOG is also the Australian and New Zealand peak professional body for paediatric oncologists and other health professionals caring for children and adolescents with cancer and blood diseases. ANZCHOG is a registered charity and not-for-profit organisation.
About Hudson
We are a global bioscience medical research leader, Hudson Institute advances healthcare through ground-breaking, collaborative medical research discoveries and their translation into real-world impact. Hudson is a community of researchers, students and professional service staff who work towards achieving discoveries that improve human health. Our discoveries impact cancer, reproductive health and pregnancy, inflammation and infant and child health. Hudson Institute provides administrative host services for ANZCHOG.
About the Opportunity
Step into a truly rewarding role within the ANZCHOG National Trials Centre, where your work directly contributes to advancing treatments for children and adolescents with cancer. As part of our dynamic team, you will support the delivery of high-quality clinical trials by performing essential quality assurance activities and conducting on-site and remote monitoring of ANZCHOG clinical trials. You’ll work closely with the National Trials Manager, Lead Clinical Trial Monitor and the broader team, and national and international collaborators across a diverse portfolio of Phase I – III paediatric oncology trials in brain cancer, leukaemia/lymphoma and solid cancers. The role offers variety, autonomy, and the opportunity to contribute meaningfully to research that addresses some of the most challenging paediatric cancers.
ABOUT YOU
Tertiary qualifications in a health-related science or health care discipline.
Minimum 2 years’ experience in clinical trial management.
Experience in risk based monitoring and on-site monitoring will be highly regarded.
Excellent working knowledge of ICH GCP, NHMRC National Statement, other NHMRC guidelines, ethical requirements, and clinical trial processes.
Experience in Oncology, Radiation Oncology or Haematology clinical trials will be highly regarded.
Experience working with collaborative group/investigator-initiated trials will be highly regarded.
Strong attention to detail, accuracy, and excellent organisational and time‑management skills.
Effective communicator with excellent interpersonal skills and the ability to work flexibly across teams and diverse stakeholders.
Able to manage multiple projects and priorities, working both independently and in a small team environment.
EMPLOYMENT TERMS
This position is a fixed term full time (1.0FTE) contract role. Salary is based on Technical and Professional Scale (TAP 7) dependent on experience. Superannuation of 12% and very attractive salary packaging options are available.
Why Work for Us
The opportunity to make a positive impact on the lives of children and adolescents affected by cancer and their families.
Access to a generous not-for-profit salary packaging program ($15,900 of salary tax fee).
Commitment to work life balance for staff, including flexible hours/ remote work from home options.
A Family Friendly Workplace.
All staff have access to our free EAP (Employee Assistance Programme) service.
How to apply?
Applications will only be accepted via our careers portal. A position description is available on our careers page https://www.hudson.org.au/careers/.
If you feel this role is the right fit for you, please apply with your resume, cover letter outlining your interest and experience, and responses against the Selection Criteria.
Applications will close on Friday 10 July. Applications will be reviewed as they come through.
OUR COMMITMENT TO DIVERSITY, equity AND INCLUSION
Hudson is committed to empowering our people and harnessing their diversity to build inclusive and equitable work environment. We actively encourage applications from, people with a disability, culturally, religiously and linguistically diverse people and people with diverse genders and sexualities. We are committed to creating a culturally safe workplace and offering career development and leadership opportunities to First Nations staff and students. We strongly encourage any Aboriginal and Torres Strait Islander peoples to apply.
Should you require support during the recruitment process due to special needs or consideration, please contact: hr•@hudson.org.au
Please note: Visa sponsorship is not available for this position. This role requires current valid work rights for Australia.
About Hudson Institute of Medical Research
The Hudson Institute is a premier Australian discovery and translation medical research institute. By unravelling the biology underlying disease the Institute will
use this information for transformative and innovative solutions to major health problems.
The Hudson Institute has diverse strengths and research excellence encompassing paediatric and perinatal medicine, cancers, infectious and inflammatory
diseases, endocrinology and reproductive health. Progressing our research requires a focused and directed strategy that incorporates thematic and
programmatic excellence across the Institute. The Institute Centres will coordinate their research activity to take advantage of novel approaches and new models
of disease. Enabling technologies will be shared and new platforms developed to meet new research challenges.
As the major research partner at the Monash Health Translation Precinct (MHTP) the Institute will underpin the research agenda of the precinct and drive
research solutions to disease, leading to better health outcomes. Sophisticated cutting edge technologies co-located with clinical and laboratory research
activities in the Translational Research Facility of the MHTP will enable the rapid translation of breakthrough discoveries to clinical care. Clinicians bring
problems they have encountered at the bedside back to the laboratories to find solutions that will enhance patient’s lives. The co-location of the Institute with
Monash Health one of the largest health care organizations in Australia, and our partnership with Monash University, the largest tertiary education and research
organisation in Australia, enables the focus to be on patient needs. The research undertaken by the Hudson Institute will address the major burdens of disease
identified as priorities by the Federal Government and National Health and Medical Research Council and will integrate its research priorities with the themes of
Monash Partners, a NHMRC accredited Advanced Health Research and Translation Centre.
Source: This extract was provided by the company.